Medical Cannabis After Rescheduling: Defending Workers' Comp Reimbursement Claims and Building Intoxication Denials That Hold at Hearing
Live · 2 CLE credits · November 23, 2026, 12:00 PM ET
Marijuana's move from Schedule One to Schedule Three has reopened workers' comp fights over medical cannabis reimbursement and intoxication denials. Assert eight reimbursement defenses, demand proof the product and expenses qualify, read urine and blood THC results correctly, and depose the claimant's toxicologist.
Rescheduling Didn’t Make Medical Cannabis Reimbursable or THC Tests Proof of Intoxication
Marijuana has moved from Schedule One to Schedule Three. Claimants now argue the Attorney General's Order ends the preemption fight over workers' comp reimbursement of medical cannabis. It does not. Schedule Three substances remain controlled substances, and state programs certify cannabis rather than prescribe it. The Order addresses FDA-approved products and qualifying state medical marijuana licenses, not every product sold in a state.
Concede preemption and Bierbach and Musta are off the table. Accept a state certification as a federal prescription and a defense is gone. Reimburse a purchase made before April 23, 2026, and you have granted a retroactive entitlement the Order never created. Urine THC-COOH and blood Delta-9 results answer different questions. Delta-8 interference changes what a positive means. A test the lab cannot defend will not carry the burden of proof in California, Florida, or Georgia.
You leave with an eight-defense framework for reimbursement claims and the proof requests to serve on every one: manufacturer, licensed-program purchase, THC composition and dosage, purchase date, itemized receipts. You also get Florida, Alabama, and Ohio's non-coverage clauses and a case-report method for reading urine, blood, and Delta-8 results, requesting lab records, and deposing the claimant's toxicologist.
Key topics
- Preemption After Rescheduling: How the move from Schedule One to Schedule Three changes the Supremacy and aiding-and-abetting argument built on the Controlled Substances Act, Bierbach, and Musta, and where Florida, Alabama, and Ohio's express non-coverage clauses leave you post-Order.
- Proof the Product Qualifies: What to demand before any product is treated as covered by the Attorney General's Order: the manufacturer, purchase through a qualifying state-licensed program, THC composition and dosage, the purchase date, and a valid federal prescription rather than a state certification.
- Reasonable and Necessary Challenges: How to attack cannabis as treatment when providers offer no rationale, no objective functional improvement, no dose or frequency specifics, no FDA approval of the product, and no national safety protocols.
- Expense Proof and Retroactivity: Which itemized receipts, dates, quantities, and out-of-pocket proof to require, and why purchases made before April 23, 2026 and previously denied claims are not reopened by rescheduling.
- Reading THC Test Results: How urine THC-COOH, blood Delta-9 THC, and Delta-8 interference each change what a positive result proves, what disqualifies a test, what to request from the lab, and when an MRO is involved.
- Carrying the Intoxication Burden: How to meet the burden of proof in California, Florida, and Georgia with toxicology evidence and depose the claimant's toxicologist on the weaknesses in the testing.
Agenda
- Defenses to Work Comp Medical Cannabis Reimbursement after rescheduling from Schedule One to Schedule Three
- Using THC Test Results to Build Intoxication Denials That Hold at Hearing
Faculty
- Susan K. H. Conley, Arthur, Chapman, Kettering, Smetak & Pikala, P.A.
- Jacob D. Farmer, Arthur, Chapman, Kettering, Smetak & Pikala, P.A.
- Margaret M. Gedde, Gedde Whole Health, LLC
State accreditation
- AK: Approved for CLE Credits, 2 General
- AL: Approved for CLE Credits, 2 General
- AR: Approved for CLE Credits, 2 General
- AZ: Approved for CLE Credits, 2 General
- CA: Approved for CLE Credits, 2 General
- CO: Pending CLE Approval, 2 General
- CT: Approved for CLE Credits, 2 General
- DC: No MCLE Required, 2 CLE Hour(s)
- DE: Pending CLE Approval, 2 General
- FL: Approved via Attorney Submission, 2 General Hours
- GA: Approved for CLE Credits, 2 General
- HI: Approved for CLE Credits, 2 General
- IA: Pending CLE Approval, 2 General
- ID: Pending CLE Approval, 2 General
- IL: Pending CLE Approval, 2 General
- IN: Pending CLE Approval, 2 General
- KS: Pending CLE Approval, 2 Substantive
- KY: Pending CLE Approval, 2 General
- LA: Pending CLE Approval, 2 General
- MA: No MCLE Required, 2 CLE Hour(s)
- MD: No MCLE Required, 2 CLE Hour(s)
- ME: Pending CLE Approval, 2 General
- MI: No MCLE Required, 2 CLE Hour(s)
- MN: Pending CLE Approval, 2 General
- MO: Approved for CLE Credits, 2.4 General
- MS: Pending CLE Approval, 2 General
- MT: Pending CLE Approval, 2 General
- NC: Pending CLE Approval, 2 General
- ND: Approved for CLE Credits, 2 General
- NE: Pending CLE Approval, 2 General
- NH: Approved for CLE Credits, 120 General minutes
- NJ: Approved for CLE Credits, 2 General
- NM: Approved for CLE Credits, 2 General
- NV: Pending CLE Approval, 2 General
- NY: Approved for CLE Credits, 2 General
- OH: Approved for CLE Credits, 2 General
- OK: Pending CLE Approval, 2.5 General
- OR: Pending CLE Approval, 2 General
- PA: Approved for CLE Credits, 2 General
- RI: Pending CLE Approval, 2.5 General
- SC: Pending CLE Approval, 2 General
- SD: No MCLE Required, 2 CLE Hour(s)
- TN: Approved for CLE Credits, 2 General
- TX: Approved for CLE Credits, 2 General
- UT: Pending CLE Approval, 2 General
- VA: Not Eligible, 2 General Hours
- VT: Approved for CLE Credits, 2 General
- WA: Approved via Attorney Submission, 2 Law & Legal Hours
- WI: Pending CLE Approval, 2 General
- WV: Pending CLE Approval, 2.4 General
- WY: Pending CLE Approval, 2 General